More than a year after its co-founders left the company, GoodRx will have a new president and CEO.
On Monday, the consumer drug pricing and digital health company announced Wendy Barnes will take over Jan. 1.
Related: GoodRx's co-founders step down as co-CEOs
Barnes most recently worked served as CEO of pharmacy benefits optimization company RxBenefits, and previously was president of pharmacy benefit manager Express Scripts. She also held roles at pharmacy chain Rite Aid and drugmaker Pfizer.
Barnes will replace interim CEO Scott Wagner, who took control after the company’s co-founders and co-CEOs Trevor Bezdek and Doug Hirsch left in April 2023. Their departures helped illustrate a broader trend of digital health company founders who were no longer leading the companies they started.
Barnes will focus on bringing more brand affordability programs to the GoodRx platform, expanding the company’s product experience with healthcare professionals, and furthering partnerships with retail pharmacies, insurers and manufacturers, the company said in a news release.
Last year, the company reached an agreement with the Federal Trade Commission after it alleged GoodRx shared consumers’ personal health information with Facebook, Google and other third parties.
